Prenatal Testing & Newborn Screening Market Outlook Signals Expansion To $12.22 Billion Through 2030

The prenatal testing and newborn screening sector is rapidly evolving, reflecting growing attention toward early detection and preventive healthcare for mothers and infants. Advances in technology and expanding healthcare initiatives are set to significantly shape this market's future trajectory. Below is an overview of the market size projections, key players, emerging trends, and segmentation within this important medical field.

Forecasted Expansion of the Prenatal Testing and Newborn Screening Market by 2030
The market for prenatal testing and newborn screening is projected to experience substantial growth over the coming years, reaching a valuation of $12.22 billion by 2030. This corresponds to a compound annual growth rate (CAGR) of 11.8%. Several factors contribute to this robust increase, including the broadening of national screening mandates worldwide, increased adoption of digital diagnostic tools, amplified investments in maternal and child healthcare, heightened attention to preventive health strategies, and the widespread use of AI-assisted diagnostic technologies. Key trends anticipated during this period encompass the integration of prenatal and newborn screening programs, the heightened application of combined screening and diagnostic methods, expanded use of early intervention protocols, automation of screening processes, and a stronger emphasis on population-level screening initiatives.

The prenatal testing & newborn screening market size has grown rapidly in recent years. It will grow from $6.98 billion in 2025 to $7.84 billion in 2026 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to expansion of public health screening initiatives, increasing institutional births, availability of neonatal care facilities, rising focus on early disease detection, improvements in diagnostic testing coverage.

Download a free sample of the prenatal testing & newborn screening market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Companies Leading the Prenatal Testing and Newborn Screening Industry
The prenatal testing and newborn screening market is shaped by numerous influential corporations. Among the major players are PerkinElmer Inc, Laboratory Corporation Of America Holdings, Natera Inc, Invitae Corporation, Centogene AG, Cradle Genomics Inc, Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc, Progenity Inc, Ravgen Inc, Strand Life Sciences Pvt Ltd, Eurofins Scientific, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F Hoffmann La Roche Ltd, Bio Rad Laboratories Inc, Siemens Healthineers AG, BGI Group, QIAGEN NV, Ariosa Diagnostics Inc, Verinata Health Inc, Counsyl A Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, and Cepheid A Danaher Company. These companies are at the forefront, driving innovation and expanding market reach globally.

Important Trends Boosting Market Growth in Prenatal Testing and Newborn Screening
Leading organizations in the prenatal testing and newborn screening arena are focusing on developing devices that enhance early detection of genetic, metabolic, and other health conditions in newborns. These innovations facilitate timely interventions that improve health outcomes. A prominent development is the introduction of point-of-care newborn screening devices designed to deliver faster, more accessible, and cost-efficient testing. For instance, in September 2023, Indian-based Mylab Discovery Solutions Pvt. Ltd. launched MyNeoShield, a newborn screening point-of-care device. This device is priced at approximately one-fifth the cost of traditional solutions, which typically range from ?50 lakhs to ?7 crores. By bringing screening capabilities directly to healthcare providers, MyNeoShield aims to widen access to critical newborn health services, especially in underserved or remote areas.

View the full prenatal testing & newborn screening market report:
https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Market Segmentation of the Prenatal Testing and Newborn Screening Industry
This market is categorized based on diagnostic types, technologies, and end users to provide a detailed understanding of its structure. The primary diagnostic types include Non-Invasive and Invasive methods. Technology segmentation covers screening and diagnostic technologies. End users are mainly hospitals and diagnostic centers. Further breakdown includes non-invasive techniques such as Blood Tests (including Cell-Free DNA Testing), Ultrasound, and Maternal Serum Screening. Invasive methods are categorized into Amniocentesis, Chorionic Villus Sampling (CVS), and Cordocentesis. This detailed segmentation helps stakeholders target their approaches more effectively across different aspects of prenatal and newborn care.

Key enhancements in our 2026 market reports include:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.